To estimate the confounding effects, we further conducted multiple comparison among BC patients of different epithelial subtypes (luminal, HER2‐enriched, triple‐negative and in situ) based on the expression level of the five identified plasma miRNAs using Kruskal‐Wallis rank test. This evidence concerns the gene ERBB2 and breast cancer.